Recruitment

Recruitment Status
Completed
Estimated Enrollment
2000

Inclusion Criteria

Intervention with Promus PREMIER everolimus eluting coronary stent
Agreed with written informed consent form
Age 20 and more
Intervention with Promus PREMIER everolimus eluting coronary stent
Agreed with written informed consent form
Age 20 and more

Exclusion Criteria

Cardiac shock
Life expectancy of 1year and under
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Cardiac shock
Life expectancy of 1year and under
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time

Summary

Conditions
  • Coronary (Artery) Disease
  • Coronary Disease
  • Heart Diseases
  • Myocardial Ischemia
  • Coronary Artery Disease
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 20 years and 125 years
Gender
Both males and females

Inclusion Criteria

Intervention with Promus PREMIER everolimus eluting coronary stent
Agreed with written informed consent form
Age 20 and more
Intervention with Promus PREMIER everolimus eluting coronary stent
Agreed with written informed consent form
Age 20 and more

Exclusion Criteria

Cardiac shock
Life expectancy of 1year and under
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time
Cardiac shock
Life expectancy of 1year and under
Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time

Tracking Information

NCT #
NCT02060968
Collaborators
  • CardioVascular Research Foundation, Korea
  • Boston Scientific Korea Co. Ltd
Investigators
Not Provided